Researchers found that GLP-1 receptor agonists (GLP-1RAs) significantly reduce the risk of several blood cancers in type 2 ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

While white collar jobs have long been associated with occupational issues such as stress and back pain, experts are warning ...

The “off-the-shelf” CAR T-cell therapy CTD402 will be evaluated in a phase 1b/2 trial for patients with T-cell acute ...

A new study has identified a critical mechanism that could lead to substantial advancements in the treatment of acute myeloid ...

Hematopoietic and lymphocytic neoplasms (HLNs) are a diverse group of malignancies affecting blood and lymphatic systems, with outcomes varying from manageable conditions to fatal diseases.

Horton was also named the Texans’ Ed Block Courage award winner in balloting from his teammates. The award is one of the most ...

The Food and Drug Administration granted fast track designation to AUTX-703 for relapsed or refractory acute myelogenous ...

Imatinib, a tyrosine kinase inhibitor of Bcr-Abl, is the current first-line therapy for patients with chronic myelogenous leukemia (CML). Despite the effectiveness of imatinib, many patients ...

Everton saw an injury-time penalty overturned as Manchester United held on to an unlikely draw at Goodison Park. The Toffees were cruising to a rare victory over United thanks to first-half goals ...